Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Venture Capital
Biotech
European VC Medicxi closes €500M biotech fund
The new oversubscribed fund follows the European firm’s $400 million fund raised back in 2023.
Gabrielle Masson
Nov 14, 2025 3:00am
Fierce Biotech Fundraising Tracker: Gate, Braveheart & more
Nov 13, 2025 6:00am
Neuphoria, reeling from ph. 3 fail, mulls buyout from investor
Nov 11, 2025 8:40am
In vivo gene editing biotech blossoms from Jennifer Doudna's lab
Nov 4, 2025 8:00am
Italian biotech raises $141M series B to fund eye gene therapies
Nov 3, 2025 3:00am
Electra shines with $183M fundraise for rare disease trial
Oct 22, 2025 8:26am
